Introduction: The Australian Government has provided $20 million to establish the Population Health Research Network (PHRN), with representation from all States and Territories to facilitate population health research through data linkage. Health LinQ is part of the Queensland node involving four Queensland universities, Queensland Health and the Australian e-Health Research Centre.

Method: This paper reviews the potential for using administrative databases to study the mental health experience of Indigenous Queenslanders. Researchers can define cohorts for study within the administrative data or link them to their own data. Robust protocols preserve confidentiality so that researchers only receive anonymized data. Indigenous status can be defined either through place of residence or through the recording of Indigenous status in datasets such as the Queensland Hospital Admitted Patient Data Collection.

Results: Available data include hospital morbidity, mental health data and mortality. Indigenous status is correctly identified in about 89% of cases with variation by definition used.

Conclusions: Administrative data provide researchers and decision makers with accessible, cost-effective information without the intrusion and cost of additional data collection. These techniques are especially useful in studying regional, rural and remote populations where access may be difficult.

Download full-text PDF

Source
http://dx.doi.org/10.3109/10398562.2011.583047DOI Listing

Publication Analysis

Top Keywords

administrative data
12
mental health
12
indigenous status
12
data
9
data provide
8
population health
8
health data
8
health
7
indigenous
5
administrative
4

Similar Publications

Background: Ovarian cancers (OC) and cervical cancers (CC) have poor survival rates. Tumor-infiltrating lymphocytes (TILs) play a pivotal role in prognosis, but shared immune mechanisms remain elusive.

Methods: We integrated single-cell RNA sequencing (scRNA-seq) and spatial transcriptomics (ST) to explore immune regulation in OC and CC, focusing on the PI3K/AKT pathway and FLT3 as key modulators.

View Article and Find Full Text PDF

Background: Artificial Intelligence (AI) is increasingly applied in healthcare to boost productivity, reduce administrative workloads, and improve patient outcomes. In nursing, AI offers both opportunities and challenges. This study explores nurses' perspectives on implementing AI in nursing practice within the context of Jordan, focusing on the perceived benefits and concerns related to its integration.

View Article and Find Full Text PDF

The experience of transition from student nurse to registered nurse among newly graduated nurses in the paediatric setting: An integrative literature review.

Nurse Educ Pract

January 2025

University of Newcastle, School of Nursing & Midwifery, College of Health Medicine and Wellbeing, Richardson Wing, Callaghan, NSW 2308, Australia; Western Sydney University, School of Nursing and Midwifery, Liverpool NSW 2170, Australia; South Western Sydney Local Health District, Liverpool, NSW 2170, Australia. Electronic address:

Aim: This integrative review explores the transition to practice experiences of graduate nurses working in either acute or non-acute paediatric settings across different countries.

Background: Graduate nurses frequently experience feelings of inadequacy, uncertainty, increased accountability, and workload pressures during their transition, particularly in paediatric settings. However, research specifically examining their experiences in paediatric healthcare is limited, with most studies focusing on broader nursing contexts.

View Article and Find Full Text PDF

Study Hypothesis: Use of opioids for treatment of headache in the emergency department (ED) is associated with an increased 1-year risk of opioid-related adverse events.

Objective: To assess the safety and efficacy of opioid prescribing for ED patients with headache.

Methods: We performed a multicenter observational cohort study using linked administrative data.

View Article and Find Full Text PDF

From Vision to Reality: The EU's Pharmaceutical Reforms and the Path to Improved Access.

Pharmacoecon Open

January 2025

Department of Health Policy and Medical Technology Research Group, LSE Health, London School of Economics and Political Science, London, UK.

Disparities in access to oncology medicines in European Union (EU) member states can impact patient outcomes profoundly, with availability and timely access varying significantly across and within member states. This paper discusses the intersection of the new European Health Technology Assessment Regulation (HTAR), the provisions of the proposed pharmaceutical legislation and their potential impacts on access to oncology medicines across EU member states. The HTAR, seeking to standardise the clinical evaluation of new medicines, has the potential to streamline the evaluation process but also risks oversimplifying diverse national healthcare needs.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!